Ibuprofen API prices jump 30% in international market due to supply crunch

German firm BASF's plant shutdown in Texas resulted in short supply

The shortage in supplies of Ibuprofen active pharmaceutical ingredient (API) globally has resulted in a 30 per cent spike in prices and the ibuprofen formulations (medicines) have seen a fall in sales in the Indian market in the past few months. Prices in the domestic market, too, are up by 20 per cent and industry insiders claimed that the offtake of the bulk drug by formulation makers has thus fallen. 

Ibuprofen is a popular drug to treat pain. The API or bulk drug (raw material) of Ibuprofen has seen supply shortages in the past nine months, first because of production